Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-001343

Chief Financial Officer acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2020-01-01 Grant or award +85,000 411,185 D: show line 1 in the form
Loading xslF345X03/doc4.xml…